Spectral karyotyping (SKY) was performed in patients with acute myeloid leukemia (AML; n = 25), secondary AML (s-AML; n = 7), myelodysplastic syndrome (MDS; n = 6) and s-MDS (n = 1) to complement conventional cytogenetic investigations. According to the results of conventional cytogenetics the patients were subdivided into three groups: group 1, normal karyotype, n = 19 cases, median age = 64 years; group 2, patients displaying either one or two single aberrations, n = 10 cases, median age = 54 years; group 3, patients with у3 independent aberrations, n = 10 cases, median age = 61.5 years. SKY identified no abnormal metaphases in group 1. In one patient of group 2 a hidden translocation t(7;14)(q3?1;q2?2) could be revealed with SKY. Conventional cytogenetics had only shown trisomy 8. A similar t(7;14) was also detected in one patient of group 3. SKY was helpful for the delineation of marker chromosomes and additional material. Furthermore, SKY could distinguish between partial and total monosomies or real existing and apparent deletions. The combination of Gbanding, FISH and SKY was found very useful for the precise delineation of the karyotype. As a result of our study we recommend SKY investigation as an important additional tool for accurate chromosome analysis. The detected t(7;14) might represent a novel recurrent translocation in acute myeloid leukemias. Leukemia (2000) 14, 1031-1038.
Introduction
Cytogenetic investigations provide important information about genetic aberrations involved in many hematological malignancies. They have paved the way for molecular analysis that have identified genes involved in the process of leukemogenesis.
An abnormal karyotype can be found in 58-80% of patients 1, 2 with AML in an age-dependent manner. Most patients have characteristic acquired chromosomal abnormalities. 2 The Medical Research Council (MRC) AML 10 trial 1 highlights the importance of diagnostic cytogenetics as an independent prognostic factor in AML. Multivariate analysis showed that the karyotype was an independent predictor of therapy response, remission duration and survival. 3, 4 Pre-treatment cytogenetics is used for risk stratification of postremission AML therapy. Bloomfield et al 5 could demonstrate that the curative impact of cytarabine intensification varies significantly among different cytogenetic groups of patients with primary AML. Ara-C treatment results in a substantial prolongation of complete remission among patients with t(8;21), inv (16) and normal karyotypes but not in those with other karyotype abnormalities.
The basis of conventional cytogenetics is the analysis of Gor R-banded metaphase chromosomes. Poorly spread or con-tracted chromosomes and highly rearranged karyotypes are often difficult to interpret unambiguously and subtle chromosomal aberrations, in particular the exchange of similar banded segments or small insertions, remain elusive.
Fluorescence in situ hybridization (FISH) has been used as an adjunct to routine cytogenetics. The diagnostic potential of customary FISH experiments does not allow the analysis of the entire chromosome set simultaneously. The information from a single hybridization is still limited to two to three chromosomes in all but a few laboratories. Also, single-or dualcolor FISH requires some prior knowledge of chromosomal origin in order to select the appropriate probe. 6 With the introduction of spectral karyotyping (SKY) 7 and the multiplexfluorescence in situ hybridization (M-FISH) 8 techniques exist which paint each of the 24 human chromosomes in a different color simultaneously. SKY combines Fourier spectroscopy, CCD imaging, and fluorescence microscopy. Using the simultaneous hybridization of 24 chromosome-specific painting probes (labeled with five different fluorochromes) the differentiation of the genetic material from every chromosome in different colors is possible. Measurement of defined emission spectra by means of interferometer-based spectral imaging and calculation with specific computer algorithms allow for karyotyping and produce the 'classified image' (for detailed information see Refs 6, 7) . The results of SKY investigation are shown in three different images: the spectral color image, the classified image (see above) and the G-banded DAPI image. The latter results from an extra acquisition with a DAPI filter set.
Here, we performed a study using SKY in AML and MDS patients in order to determine whether this novel technique is helpful in detecting hidden translocations or insertions, especially in patients with a normal karyotype or with single aberrations. Since patients showing a normal karyotype or single aberrations without high-risk impact are still heterogeneous in their clinical course, we wanted to investigate the idea whether SKY analysis could provide additional information for risk stratification in this patient group.
In addition, the group of patients with complex rearranged karyotypes was of specific interest. Approximately 10% of all patients with an abnormal karyotype have complex aberrant chromosome sets. Results of therapeutical interventions are still unsatisfactory in this group. Thus we asked whether SKY technology could clarify the complex aberrations more precisely, which might be useful for new therapies adapted individually to specific chromosomal changes.
Materials and methods
Thirty-nine patients were investigated. They were recruited from the routine sample from patients treated in our institution (eg for allogeneic bone marrow transplantation). Samples from patients treated in the multi-center AML SHG96 trial were ␣-satellite.
received from the central study cell bank. The patients suffered from AML (n = 25), s-AML (n = 7), MDS (n = 6) and s-MDS (n = 1). Twenty-eight patients were included in the SHG AML96-trial (AML or s-AML: n = 27, RAEB-T: n = 1), where patients less than 60 years received an induction with ara-C 8 × 100 mg/m 2 , etoposide 5 × 100 mg/m 2 and mitoxantrone 5 × 10 mg/m 2 . 9 On day 28 ara-C 5 × 2000 mg/m 2 and amsacrine 5 × 100 mg/m 2 was infused. Patients older than 65 years were treated with 2 × 45 mg/m 2 daunorubicine and 7 × 100 mg/m 2 ara-C. The other patients were treated individually.
For SKY investigation patients were selected according to their G-banding karyotype and classified into three karyotype groups: group 1 (normal karyotype) n = 19, median age = 64 years, range: 33-73 years, 10 female, nine male (characteristics of patients are given in Table 1 ); group 2 (one up to two single karyotype aberrations) n = 10, median age = 54 years, range: 18-73 years; group 3 (complex aberrant karyotype with у3 independent aberrations) n = 10, median age = 61.5 years, range: 36-74 years. Details of the clinical data and sex of group 2 and group 3 patients respectively are listed in Table 1 .
Thirty-four samples were obtained with informed consent at primary diagnosis, seven samples at the time of relapse or advanced stages.
We used freshly prepared slides from methanol/acetic acid fixed cells. Cytogenetic cultures to obtain metaphases were performed using bone marrow (n = 33) and peripheral blood (n = 8) samples. Chromosome preparation, GTG-and GAGbanding techniques were performed as described elsewhere. Single-or dual-color FISH analyses were performed in addition to SKY investigation in cases with questionable rearrangements and for a better identification of chromosome segments in which the breaks may have occurred.
The SpectraCube system equipped with the software SkyView 1.2 (Applied Spectral Imaging) was used. In FISH experiments, metaphases were captured with the software package ISISF (META Systems, Altluβheim, Germany).
Results
The results of conventional cytogenetic analysis and SKY are included in detail in Table 1 . The enumeration of the DNA probes used in single-or dual-color FISH are given in the FISH column.
Group 1: normal karyotype
With conventional cytogenetic investigations, patients SID 1 (study identification number) to SID 16, and SID 34 to 36 showed a normal female and male karyotype respectively. A median of 10 metaphases were analyzed per patient (range: 5-15 metaphases) with SKY to confirm conventional cytogenetics. Hidden aberrations were not detectable in this group.
Group 2: aberrant karyotype, but not complex
A hidden translocation t(7;14) was discovered with SKY (SID 23, Figure 1 In addition to the karyotypes listed in Table 1 , metaphases of one patient (SID 24) showed several non-clonal aberrations. For example, the duplicated abnormal chromosome 1, a trisomy 4, and a trisomy 12 were detectable with SKY.
Group 3: complex aberrant karyotype
SKY could identify all of the involved chromosomes in seven out of 10 patients (SID 25, 26, 27B, 28, 29, 30, 37) or most of them (SID 31, 32, 38). In all these cases, SKY gave a more comprehensive karyotype description than conventional cytogenetics. The unidentified aberrations were one up to three marker chromosomes (SID 31, 32) and heterogeneous anomalies (SID 38). Of special interest was the fact, that not only the documentation of structural rearrangements was improved but also numerical aberrations could be detected with the SKY technique (−Y in SID 31).
Each of the three different cytogenetic tools (banding, SKY and FISH) had specific advantages in certain samples. For reliable recognition of small deletions the results obtained with banding were most valuable (SID 25). On the other hand, G-banding was not able to detect translocations of 20q. SKY revealed the involvement of the apparently deleted 20q segments in translocations (SID 25, 29, 31, 38) . Moreover, some monosomies detected by G-banding were not correct. In fact, ;14) were detectable besides a normal female karyotype. The AML blasts were refractory to induction chemotherapy in this patient. Tumor cell expansion led to a disappearance of normal metaphases 7 weeks after diagnosis of AML (23B). In patient SID 25 the t(7;14) was unbalanced and accompanied by trisomy 8 and aberrations of chromosome 13 and 20. The insufficient material did not allow further investigation of metaphases to proof the 7 q-break with the LSI 7q31 (O) and WCP 14 (G) probe set.
parts of the apparently lost chromosomes were still present as shown with SKY (Nos 5 in SID 31, X and 7 in SID 26, 22 in SID 27B, 18 in SID 30). However, only the FISH experiment documented the insertion of a small chromosome 6 segment into the derivative chromosome 13 (SID 29, Figure 2) .
While the banding technique could only establish the involvement of some chromosomes and failed to detect mosaicism of complex aberrant karyotypes, SKY revealed the existence of two (SID 25) or several (SID 28, 38) sidelines. Non-clonal aberrations were detected with the help of SKY in patient SID 28. Surprisingly, the translocation t(7;14), which had already been detected in patient SID 23 of group 2, was also found in one patient of group 3 (SID 25, Figure 1) .
In patient SID 30, a classical 5q− chromosome was susLeukemia pected with cytogenetics. SKY showed a der(5)t(5;18). Probably, a primary 5q− chromosome was modified by a secondary event.
There were no special selection criteria for the aberrant cases investigated with SKY. Thus, the frequent involvement of chromosomes 5q, 6p, 6q, 7q, 12p, 13q, 20q and 22q in structural rearrangements and the loss of chromosome 7 in the complex aberrant karyotype group seems remarkable for an unselected group of patients.
Discussion
We have compared the abilities of conventional G-banding and FISH with the new technique of spectral karyotyping in SKY and FISH results in patient SID 29. Top row and bottom row left: DAPI, classified and spectral color image, SKY karyotype. Arrows denote der(6)t(6;13), der(13) and t(20;22). The classified image had only shown the involvement of chromosome 22 in forming der (13) . Bottom row right: Two partial metaphases, hybridization results with WCP 13 and WCP 22 respectively WCP 6 and WCP 20. The upper metaphase shows a normal chromosome 22 and 13, respectively, der(13) with an inserted segment and added chromosome 22 material, der(6) with the translocated segment of chromosome 13. The inserted segment of der (13) is only colored with the DAPI counterstain. The other metaphase shows a normal chromosome 6 and 20, respectively, an abnormal chromosome 6 (der(6)t(6;13)), the insertion of chromosome 6 material into a D-type chromosome (der(13)t(6;13;22)), a smaller chromosome 20 and a chromosome to which material from chromosome 20 was translocated (t (20;22) ). 39 patients with AML or MDS. Our data show that SKY was useful for the delineation of marker chromosomes and additional material (SID 37, 39). Furthermore, SKY could distinguish better between partial and total monosomies or between obvious and suspected deletions. Spectral karyotyping was especially helpful in the discrimination between stemline, side-lines and unrelated clones or non-clonal events. The latter may be induced by radiotherapy or by a distinct karyotype instability frequently observed in patients with MDS. 12 Additionally, SKY provided information on the pathway of clonal evolution, while identifying the basic aberration and the arising side-lines (SID 25, 27, 30, 31). For example, conventional cytogenetic investigation failed to detect the fragmented 12p− chromosome in patient SID 27(B) in whom secondary leukemia had been assumed. SKY gave evidence for the pathogenesis and proved that the malignant disorder was in fact a relapse of the first leukemia. Nevertheless, SKY revealed several limitations due to technical constraints, which make it impossible to rely solely on this technique. This fact has to be kept in mind when results of SKY analysis are interpreted.
The most important limitation is that the SKY technique is restricted to the number of metaphases spread in the hybridization area. Since conventional cytogenetics allows the analysis of numerous dropped slides, this technique is more sensitive in the detection of small subclones (SID 19) .
Furthermore the quality of the SKY results strongly depends on the amount of cytoplasm remaining after the hybridization procedure. A large amount of cytoplasm may lead to crosshybridization and misclassification of some chromosomes. This became problematic in highly rearranged karyotypes with marker chromosomes composed of numerous insertions. As a result, it was impossible to identify all of the markers (SID 31, 32, 38). Besides that, one has to keep in mind that all of the 24 chromosomes were painted with five different colors and up to four distinct colors had to be used for the painting of a unique chromosome. If the involved chromosomes are composed of similar colors, the emitted spectra might overlap. This could cause problems in the discrimination of signals. In our investigations this became obvious in patient SID 29, where SKY revealed involvement of chromosomes 13 and 22 whereas FISH revealed an inserted segment of chromosome 6 between the material from chromosomes 13 and 22 ( Figure 2) .
As noted by Rowley and co-workers, 13 the DAPI image which has to be generated for the SKY analysis is still not as precise as G-banded metaphase cells because of the harsh treatment of chromosomes during the hybridization process. In our patients using the SKY technique, we misinterpreted the breaks of a deleted chromosome 7 (SID 25) and could not detect a deletion in 12p (SID 25).
Beside these limitations in methodology, SKY revealed several interesting data which might point to novel cytogenetic abnormalities in AML and MDS.
We identified two patients carrying a translocation t(7;14) as a recurring rearrangement (SID 23, 25) . This translocation was not detectable with G-banding analysis. Both were elderly patients and the t(7;14) was accompanied by trisomy 8 in both cases. SKY did not allow precise allocation of the 14q breakpoints, and FISH analysis indicated a 7q− breakpoint telomeric to band 7q31 in one patient (SID 23). Using SKY technique, Veldman and co-workers 14 recently also demonstrated a case of a translocation t(7;14) in 63-year-old patient with AML. In this case the translocation was unbalanced with suspected breaks in 7q22 and 14q?. Interestingly, in this case the t(7;14) was also accompanied by a +8, beside other aberrations (t(Y;12), −5). Taken together, the translocation t(7;14) might represent a novel recurrent translocation, worth keeping in mind in further studies on AML.
In group 3, we frequently observed structural rearrangements in 5q, 6p, 6q, 7q, 12p, 13q, 20q and 22q and a monosomy 7. Comparing these results with the literature, we found the anomalies −7, del(5q), der(3p), der(6p), del(7q), der(12p), del(20q) and −18 most frequently reported in primary or secondary AML and MDS, respectively. A deletion in 13q is most often associated with MDS but is not listed among the most consistent AML aberrations. 2 In detail, five patients (SID 24, 25, 26, 28, 38) had a 5q− chromosome, of which four patients were classified to have a complex aberrant karyotype. The results of chromosomal analyses implied the 5q− chromosome as the primary aberration. All of the patients with abnormal 5q (n = 6, group 3) were either elderly or diagnosed with MDS or with secondary AML. The 5q− chromosome is one of the most common cytogenetic abnormalities in s-AML and MDS and one of the typical features in patients who had received alkylating agents. 2, 15 In four out of 10 patients of karyotype group 3, translocations involving chromosomal region 20q were detected with SKY. In another patient, the long arm of chromosome 20 was deleted. G-banding was less informative, since only a 20q− chromosome was suspected. Thus, many cited 20q− anomalies might in fact represent hidden translocations. To clarify this definitely, the use of chromosome painting investigations (FISH, SKY, M-FISH) seems to be important.
All 10 patients out of karyotype group 3 were either elderly or suffered from secondary AML, s-MDS or MDS. Interestingly, the frequency of therapy-related acute leukemia and myelodysplastic syndrome has increased during the last decade. 16 Dose intensification of cytotoxic drugs and the increased usage of etoposide may contribute to these observations.
The multi-chromosomal karyotype changes observed in group 3 might suggest that these leukemias could represent more progressed diseases involving multiple genes. Most important in this respect are changes activating oncogenes or inactivating tumor suppressor genes.
In karyotype group 3 we observed anomalies of 13q− regions in five out of 10 patients. The RB-tumor suppressor gene has been allocated to band 13q14, but there are also indicators for additional tumor suppressor genes located in this chromosomal region. 17 Another gene, TEL, also known as ETV6 gene, on chromosome 12p13 is the target of a number of translocations in leukemias. 18, 19 In our patients with complex aberrations, the chromosomal region 12p was involved in four cases. As shown by FISH analysis, TEL was monoallelic deleted in all these patients (del(12p) in SID 25, 26, 27, and unbalanced translocation t(5;12) in SID 31 respectively). In the published investigations the 12p aberrations were found to be the sole abnormality as well as to be involved in complex multichromosomal changes. Chase and co-workers 20 found ETV6 disrupted in three AML patients with a t(12;13)(p13;q12).
The rapid clonal evolution detected with cytogenetics at leukemic relapse in patient SID 27 12 months later could have been caused by the deletion of ETV6, whereas the 2nd allele might have been modified by a mutation. In addition, the monoallelic deletion of chromosome 17p13, found at the time of leukemic relapse by FISH analysis, indicated the involveLeukemia ment of the tumor suppressor gene p53 in this patient. Wildtype p53 arrests cell cycle progression until DNA damage is repaired or directs cells along the path of apoptosis. To confirm a complete abrogation of the p53 function in this case, SSCP (single strand conformation polymorphism) analysis and sequencing were performed, which revealed a TGT-TAT missense mutation in codon 277 (Cys-Tyr).
In conclusion, the simultaneous use of G-banding, FISH and SKY allowed precise delineation of chromosomal abnormalities. Especially in patients with complex karyotypes this fact appears to be of importance. The identification of deleted regions could point to the involvement of tumor suppressor genes, which could be helpful in identifying patients with poor prognosis. SKY was able to correct the results obtained by standard G-banding, especially in 20q− cases and suspected monosomies. These more precise karyotype data might be helpful in defining subgroups of patients with different clinical behavior in the large group of patients with complex karyotype.
However, no additional abnormalities were detected in the group of patients with normal karyotype. Rowley et al 13 recently published similar data in 15 patients with T-ALL. They did not identify any additional anomalies in the five patients with a normal karyotype. Thus in the future, in this group of patients, novel techniques such as high density arrays screening the expression of several thousand genes simultaneously might be helpful for the identification of specific patterns associated with poor prognosis. 21 
